Latest News for: Pharmaceutical sources

Edit

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

Pharmiweb 31 Mar 2025
Hemogenyx Pharmaceuticals plc ... About Hemogenyx Pharmaceuticals plc. Hemogenyx Pharmaceuticals is a publicly traded company (LSE ... Hemogenyx Pharmaceuticals is ... SOURCE. Hemogenyx Pharmaceuticals PLC.
Edit

Citrus Oil Formula May Relieve Dry Mouth for Cancer Patients

Guam Pacific Daily News 29 Mar 2025
Mar 30, 2025 1 hr ago 0. Facebook Twitter WhatsApp SMS Email. Photo of an essential oil and lemons on a wooden cutting board ... More from this section ... The findings were recently published in the International Journal of Pharmaceutics ... SOURCE ... Tags ... Cancel.
Edit

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

ACCESSWIRE 28 Mar 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc ... ("IMS"), a subsidiary of Amphastar Pharmaceuticals, Inc ... Amphastar's Chinese subsidiary, Amphastar Nanjing Pharmaceuticals, Co., Ltd ... SOURCE.
Edit

Protect global trade, China's Xi urges multinational CEOs

The Manila Times 28 Mar 2025
Around 40 executives joined the meeting, the majority of whom represented the pharmaceuticals sector. The meeting ran for just over 90 minutes and seven companies were invited to speak, a source with direct knowledge of its planning said ... ....
Edit

Washington tells EU to brace for more tariffs before negotiations

Business Day 27 Mar 2025
It’s just a guess,” one of the sources said ... autos, pharmaceuticals, timber, semiconductors and metals. In Europe, Washington has been closely eying competition in autos and pharmaceuticals.
Edit

Washington told EU to brace for more tariffs before any talks, envoys say

Colorado Springs Gazette 27 Mar 2025
"It's just a guess," one of the sources said ... autos, pharmaceuticals, timber, semiconductors and metals. In Europe, Washington has been closely eying competition in autos and pharmaceuticals.
Edit

India eyes tariff cuts on $23B of US imports to avoid Trump’s reciprocal taxes: report

New York Post 26 Mar 2025
... sources familiar with the matter told Reuters ... Trump’s tariffs on pharmaceutical drugs and the auto industry could also hit India hard, since it is dependent on the US market, one of the sources said.
Edit

CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme

ACCESSWIRE 25 Mar 2025
"Clinical results in a prior Phase 1 trial indicated Berubicin's potential to improve outcomes for patients with previously treated Glioblastoma," said Sandra Silberman, MD, PhD, Chief Medical Officer of CNS Pharmaceuticals ... SOURCE.
Edit

India open to tariff cuts on more than half of US imports to shield exports, sources say

Business Day 25 Mar 2025
In an internal analysis, New Delhi estimated such reciprocal tariffs would hit 87% of its total exports to the US worth $66bn, two government sources with knowledge of the matter said ... sources said.
Edit

India eyes tariff cut on more than half of US imports to shield its exports, sources say

Khaleejtimes 25 Mar 2025
India is open to cutting tariffs on more than half of US imports worth $23 billion in the first phase of a trade deal the two nations are negotiating, two government sources said, the biggest cut in years, aimed at fending off reciprocal tariffs.
Edit

Exclusive-India eyes tariff cut on more than half of US imports to shield its exports, ...

News India Times 25 Mar 2025
imports worth $23 billion in the first phase of a trade deal the two nations are negotiating, two government sources said, the biggest cut in years, aimed at fending off reciprocal tariffs.
Edit

Hemogenyx Pharmaceuticals PLC Announces First Patient Safety

ACCESSWIRE 24 Mar 2025
Hemogenyx Pharmaceuticals plc. ("Hemogenyx Pharmaceuticals" or the "Company") ... Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented. ... Hemogenyx Pharmaceuticals plc ... About Hemogenyx Pharmaceuticals plc ... SOURCE.
Edit

MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5 Million ...

ACCESSWIRE 24 Mar 2025
MIAMI, FL / / March 24, 2025 / MIRA Pharmaceuticals, Inc ... Despite the burden these conditions place on public health, existing pharmaceutical treatments remain limited, expensive, and often ineffective ... SOURCE. MIRA Pharmaceuticals, Inc.
Edit

DEA's Marijuana Policy Mission at Odds with Its Actions - MMJ's DEA Lawsuit Positioned to Win

ACCESSWIRE 23 Mar 2025
Prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs ... SOURCE.
Edit

Pharma firm enthused by deep access to China

China Daily 21 Mar 2025
"We see China as a source of innovation, and the country has made tremendous strides in creating an ecosystem that empowers innovators," said Jean-Christophe Tellier, CEO of UCB, a multinational biopharmaceutical company.
×